European shares up as new COVID-19 vaccine lift hopes

European shares up as new COVID-19 vaccine lift hopes

European shares were slightly higher on Tuesday after market sentiment was boosted by optimism with a potential COVID-19 vaccine.

A report by the Financial Times stipulated that the U.S. had fast-tracked a potential COVID-19 treatment developed by the University of Oxford and AstraZeneca to be ready before the November elections.

European shares opened higher, with the bullish mood continuing in sessions in New York and Asia.

The STOXX 600 saw record gains, gaining 0.4% for the day on Monday at 0803 GMT, while London’s FTSE 100 rose by 0.3%.

The MSCI world equity index, which tracks shares in 49 countries, was up 0.2%. MSCI’s main European Index was up 0.7%.

However, a spokeswoman for AstraZeneca denied the company had discussed an emergency use authorization for its potential vaccine with the U.S. government.

The director of the Oxford Vaccine Group added on Tuesday that the vaccine could be put before regulators this year.

Risk disclaimer "PROMETHEUS LTD – Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Republic of the Marshall Islands MH96960 is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0155 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of PROMETHEUS LTD and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from or PROMETHEUS LTD." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue

Help with deposit?